TMPRSS2 and prostate carcinoma: Since PSMA is a promising target for prostate cancer therapy and imaging, further elucidation of the relationship between TMPRSS2 gene fusions and PSMA could reveal novel pathways for enhancing targeted prostate cancer treatment.